Journals / Endoüroloji Bülteni / 2026 / Cilt: 18 Sayı: 3

Clinical Outcomes of Antegrade Double-J Stent Placement in Patients with Failed Retrograde Ureteral Stenting

Retrograd Üreteral Stentlemenin Başarısız Olduğu Hastalarda Antegrad Double-J Stent Uygulamasının Klinik Sonuçları

Pages
150–159
Publication Date
2026-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall complication rate was 7.5%, and all complications were minor and resolved with conservative management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to evaluate the technical and clinical success, complication profile, and clinical effectiveness of antegrade double-J (DJ) stent placement in patients in whom retrograde ureteral stenting had failed.
📊
Key Findings & Data:Materials and Methods: This retrospective study included patients who underwent antegrade DJ stent placement between 2021 and 2025 due to unsuccessful retrograde access.
💡
Conclusion & Impact:The overall complication rate was 7.5%, and all complications were minor and resolved with conservative management.
🔬Design:Araştırma Makalesi
📍Scope:2021 Verileri
⚙️Variables:üreteral obstrüksiyon · stent · perkütan nefrostomi

Abstract

Objective: This study aimed to evaluate the technical and clinical success, complication profile, and clinical effectiveness of antegrade double-J (DJ) stent placement in patients in whom retrograde ureteral stenting had failed. Materials and Methods: This retrospective study included patients who underwent antegrade DJ stent placement between 2021 and 2025 due to unsuccessful retrograde access. All procedures were performed under ultrasonographic and fluoroscopic guidance. Patients were categorized into single-stage and 2-stage antegrade stenting groups based on their clinical condition. All interventions were performed by a single experienced interventional radiologist. Technical and clinical success rates were assessed, and procedure-related complications were classified according to the Society of Interventional Radiology (SIR) guidelines. Results: A total of 40 patients were included in the study; 45.0% were treated for benign and 55.0% for malignant ureteral obstruction. Antegrade double-J stent placement was technically successful in all patients, with a significant reduction in the degree of hydronephrosis observed after the procedure. Clinical evaluation demonstrated a statistically significant decrease in serum creatinine levels and visual analog scale (VAS) pain scores at 24 hours post-procedure (p < 0.001). No clinically significant decrease in hemoglobin levels was observed. The overall complication rate was 7.5%, and all complications were minor and resolved with conservative management. Conclusion: Antegrade DJ stenting represents a safe, effective, and minimally invasive alternative in patients with failed retrograde access. When performed within a multidisciplinary framework involving urology and interventional radiology, this approach improves patient comfort and reduces the need for long-term percutaneous nephrostomy.

Özet

Amaç: Bu çalışmanın amacı, retrograd üreteral stent yerleştirmenin başarısız olduğu hastalarda antegrad double-J (DJ) stent uygulamasının teknik ve klinik başarısını, komplikasyon profilini ve klinik etkinliğini değerlendirmektir. Gereç ve Yöntemler: Bu retrospektif çalışmaya, 2021–2025 yılları arasında retrograd girişimin başarısız olması nedeniyle antegrad DJ stent uygulanan hastalar dahil edildi. Tüm işlemler ultrasonografi ve floroskopi rehberliğinde gerçekleştirildi. Hastalar klinik durumlarına göre tek aşamalı ve çift aşamalı antegrad stentleme gruplarına ayrıldı. Tüm işlemler tek bir girişimsel radyoloji uzmanı tarafından gerçekleştirildi. Teknik ve klinik başarı oranları değerlendirildi. İşleme bağlı komplikasyonlar Society of Interventional Radiology (SIR) sınıflamasına göre kategorize edildi. Bulgular: Toplam 40 hastanın dahil edildiği çalışmada olguların %45,0’ı benign, %55,0’ı malign nedenlere bağlı üreteral obstrüksiyon nedeniyle tedavi edildi. Antegrad double-J stent yerleştirilmesi tüm hastalarda teknik olarak başarılı olup, işlem sonrası hidronefroz derecelerinde anlamlı gerileme saptandı. Klinik değerlendirmede, serum kreatinin düzeyleri ve VAS ağrı skorlarında işlem sonrası 24. saatte istatistiksel olarak anlamlı düşüş izlendi (p < 0,001). Hemoglobin düzeylerinde klinik olarak anlamlı bir kayıp izlenmedi. Komplikasyon oranı %7,5 hesaplandı ve yalnızca minör düzeyde olup konservatif tedavi ile düzeldi. Sonuçlar: Antegrad DJ stentleme, retrograd girişimin başarısız olduğu olgularda güvenli, etkili ve minimal invaziv bir alternatif olarak öne çıkmaktadır. Üroloji ve girişimsel radyoloji disiplinlerinin multidisipliner yaklaşımı ile uygulandığında hasta konforunu artırmakta ve uzun süreli perkütan nefrostomi gereksinimini azaltmaktadır.

🔖

Cite This Article

Aydın, F., Yeşilyurt, M., İbiş, E., Demirdöğen, Ş. O. (2026). Clinical Outcomes of Antegrade Double-J Stent Placement in Patients with Failed Retrograde Ureteral Stenting. Endoüroloji Bülteni, Cilt: 18 Sayı: 3, 150–159. https://doi.org/10.54233/endourolbull-1885162

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (22)

  1. Hsu L, Li H, Pucheril D, Hansen M, Littleton R, Peabody J, Sammon J. Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction. World J Nephrol. 2016;5(2):172–81. https://doi.org/10.5527/wjn.v5.i2.172
  2. Tlili G, Ammar H, Dziri S, Ben Ahmed K, Farhat W et al. Antegrade double-J stent placement for the treatment of malignant obstructive uropathy: A retrospective cohort study. Ann Med Surg (Lond). 2021;69:102726. https://doi.org/10.1016/j.amsu.2021.102726
  3. Bernasconi V, Tozzi M, Pietropaolo A, De Coninck V, Somani BK et al. Comprehensive overview of ureteral stents based on clinical aspects, material and design. Cent European J Urol. 2023;76(1):49–56. https://doi.org/10.5173/ceju.2023.218
  4. Asakawa J, Iguchi T, Tamada S, Ninomiya N, Kato M et al. Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents. Cancer Manag Res. 2018;10:2977–2982. https://doi.org/10.2147/CMAR.S172283
  5. Kim HJ, Yoon CJ, Lee S, Lee JH, Choi WS et al. Comparison between Antegrade versus Retrograde Ureteral Stent Placement for Malignant Ureteral Obstruction. J Vasc Interv Radiol. 2022;33(10):1199–1206. https://doi.org/10.1016/j.jvir.2022.06.024
  6. Ghasemi-Rad M, Trinh K, Wynne D, Ahmadzade M, Shamim MH et al. Nephrostomy (PCN) versus nephroureteral stent (Double JJ); An ongoing battle. Urologia. 2025;92(3):424–431. https://doi.org/10.1177/03915603251316702
  7. Kahriman G, Özcan N, Doğan A, İmamoğlu H, Demirtaş A. Percutaneous antegrade ureteral stent placement: single center experience. Diagn Interv Radiol. 2019;25(2):127–133. https://doi.org/10.5152/dir.2019.18252
  8. Santos RFT, Tibana TK, Marchiori E, Nunes TF. Antegrade insertion of a double J catheter in the treatment of malignant ureteral obstruction: a retrospective analysis of the results obtained with a modified technique at a university hospital. Radiol Bras. 2020;53(3):155–160. https://doi.org/10.1590/0100-3984.2019.0090
  9. Ahmad MU, Siddiqui S, Ashraf FA, Iqbal R, Ehsanullah SAM, et al. Retrograde Ureteral Stents Versus Percutaneous Nephrostomy in the Management of Malignant Ureteral Obstruction: A Systematic Review and Meta-Analysis. Urology. 2024;192:158–167. https://doi.org/10.1016/j.urology.2024.05.042
  10. Kim SH, Park B, Joo J, Joung JY, Seo HK et al. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction. PLoS One. 2017;12(9):e0184965. https://doi.org/10.1371/journal.pone.0184965
  11. Dagli M, Ramchandani P. Percutaneous nephrostomy: technical aspects and indications. Semin Intervent Radiol. 2011;28(4):424–37. https://doi.org/10.1055/s-0031-1296085
  12. Grubert RM, do Carmo CEF, Morais Neto RS, Tibana TK, Santos RFT et al. Antegrade double-J stenting as an alternative to the retrograde approach: experience of the first 150 cases at a single center in Brazil. Radiol Bras. 2021;54(6):353–359. https://doi.org/10.1590/0100-3984.2020.0131
  13. Song Y, Fei X, Song Y. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies. Int J Gynecol Cancer. 2012;22(4):697–702. https://doi.org/10.1097/igc.0b013e318243b475
  14. Tibana TK, Grubert RM, Santos RFT, Fornazari VAV, Domingos AA et al. Percutaneous nephrostomy versus antegrade double-J stent placement in the treatment of malignant obstructive uropathy: a cost-effectiveness analysis from the perspective of the Brazilian public health care system. Radiol Bras. 2019;52(5):305–311. https://doi.org/10.1590/0100-3984.2018.0127
  15. Shoshany O, Erlich T, Golan S, Kleinmann N, Baniel J et al. Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study. BMC Urol. 2019;19(1):79. https://doi.org/10.1186/s12894-019-0510-4
  16. van der Meer RW, Weltings S, van Erkel AR, Roshani H, Elzevier HW et al. Antegrade Ureteral Stenting is a Good Alternative for the Retrograde Approach. Curr Urol. 2017;10(2):87–91. https://doi.org/10.1159/000447157
  17. Friedersdorff F, Weinberger S, Biernath N, Plage H, Cash H et al. The Ureter in the Kidney Transplant Setting: Ureteroneocystostomy Surgical Options, Double-J Stent Considerations and Management of Related Complications. Curr Urol Rep. 2020;21(1):3. https://doi.org/10.1007/s11934-020-0956-7
  18. Siddiqui HU, Isaacson D, Refaai K, Lin YC, Venkatesh K et al. Management of Renal Transplant Ureteral Strictures: Versatility of a Robotic-Assisted Approach. J Endourol. 2025;39(11):1139–1148. https://doi.org/10.1089/end.2025.0308
  19. Guachetá-Bomba PL, Echeverría-García F, García-Perdomo HA. Predictors for failure of endoscopic ureteric stenting in patients with malignant ureteric obstruction: systematic review and meta-analysis. BJU Int. 2021;127(3):292–299. https://doi.org/10.1111/bju.15237
  20. Ordek E, Kolu M, Demir M, Kati B, Pelit ES et al. Antegrade placement of JJ catheter in the treatment of malignant ureteral obstruction: Retrospective analysis of a single centre. Arch Ital Urol Androl. 2022;94(1):91–96. https://doi.org/10.4081/aiua.2022.1.91
  21. Lu DS, Papanicolaou N, Girard M, Lee MJ, Yoder IC. Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases. Clin Radiol. 1994;49:256–261. https://doi.org/10.1016/S0009-9260(05)81852-5
  22. Akıncı D, Ünal E, Çiftçi TT, Özkan OŞ, Akhan O. Malign üreter tıkanıklığında tek çift J stent yetmezliğinin yönetimi: daha az sıklıkta stent değişimi ile tandem üreter stentleme. Diagn Interv Radiol. 2023;29(2):312–317. https://doi.org/10.5152/dir.2022.21638